Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370549A1 Methods for the preparation of mirtazapine intermediates
12/17/2003EP1370547A1 Benzoaxathiepin derivatives and their use as medicines
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370544A1 Nitric oxide donors based on metallic centres
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370529A1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370518A2 Tryptase-inhibitors
12/17/2003EP1370297A2 Method and composition
12/17/2003EP1370290A2 Molecular antigen array
12/17/2003EP1370289A2 Method for producing a vaccine containing autologous antibodies
12/17/2003EP1370282A2 Method for treating ischemic events affecting the central nervous system
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370275A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
12/17/2003EP1370274A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases
12/17/2003EP1370271A2 A process for the manufacture of a herbal composition comprising a matrine
12/17/2003EP1370268A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
12/17/2003EP1370262A1 New use of iloperidone
12/17/2003EP1370259A1 Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1370212A1 System and method for intranasal administration of lorazepam
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1370150A1 One-step process for preparing chewing gum
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1263425B1 Use of comt inhibitors as analgesics
12/17/2003EP1226131B1 Isoxazolecarboxamide derivatives
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1112065B1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP1051392B1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
12/17/2003EP1023296B1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
12/17/2003EP1001752B1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0980241B1 Gelatine encapsulated solution dosage forms of sertraline
12/17/2003EP0900212B1 Chiral phenyldihydrofuranones as pde-iv inhibitors
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462277A Pharmaceutical composition comprising analgesic peptide
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/17/2003CN1462188A Compositions for regulating desire for smoking
12/17/2003CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese
12/17/2003CN1461647A Traditional Chinese medicine prepn. for sobering up and preventing drunken and its prepn. method
12/17/2003CN1131237C Usage of steroi saponin for preventing and curing senile dementia and new steroi saponin
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131226C Novel 1,2-amylic cycle disulfide, its preparation method and medicinal compositions containing same
12/17/2003CN1131214C Tetrahy droquimoline derivatives as EAA antagonists
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131203C Method for separating tramadol raceme
12/17/2003CN1131063C Medicine for kidney invigorating and yang strenthening and its preparation method
12/17/2003CN1131050C Medicinal particles for treating diabetic preipheral nearopathy and preparation method thereof
12/17/2003CN1131035C Method for treating recongnitive dysfunction
12/17/2003CN1131031C Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives for NMDA receptor subtype blockers
12/17/2003CN1131030C Sleep regulating composition prepared with melatonin and diazepam
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6664283 6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2 -carboxamide dihydrochloride; mGluR1 antagonist
12/16/2003US6664274 Piperidine derivatives as serotonine reuptake inhibitors
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664252 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664068 Antibodies, antiapoptotic agents
12/16/2003CA2382275C Modafinil having defined particle size
12/16/2003CA2341805C Controlled release formulation of divalproex sodium
12/16/2003CA2275299C Indane or dihydroindole derivatives
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/16/2003CA2093125C Angiotensin ii antagonists
12/11/2003WO2003102587A1 Disc1 partners
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof
1 ... 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 ... 1833